CY2216B1 - Enzymatic hydroxylation process for the preparation of hmg-coa reductase inhibitors and intermediates thereof - Google Patents

Enzymatic hydroxylation process for the preparation of hmg-coa reductase inhibitors and intermediates thereof

Info

Publication number
CY2216B1
CY2216B1 CY0000057A CY0000057A CY2216B1 CY 2216 B1 CY2216 B1 CY 2216B1 CY 0000057 A CY0000057 A CY 0000057A CY 0000057 A CY0000057 A CY 0000057A CY 2216 B1 CY2216 B1 CY 2216B1
Authority
CY
Cyprus
Prior art keywords
hmg
preparation
coa reductase
reductase inhibitors
intermediates
Prior art date
Application number
CY0000057A
Other languages
English (en)
Inventor
Brian L David
Paul M Cino
Laszlo Szarka
Original Assignee
Bristol Myers Quibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Quibb Company filed Critical Bristol Myers Quibb Company
Publication of CY2216B1 publication Critical patent/CY2216B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/872—Nocardia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY0000057A 1993-10-22 2000-11-28 Enzymatic hydroxylation process for the preparation of hmg-coa reductase inhibitors and intermediates thereof CY2216B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/141,316 US6043064A (en) 1993-10-22 1993-10-22 Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof

Publications (1)

Publication Number Publication Date
CY2216B1 true CY2216B1 (en) 2003-04-18

Family

ID=22495167

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0000057A CY2216B1 (en) 1993-10-22 2000-11-28 Enzymatic hydroxylation process for the preparation of hmg-coa reductase inhibitors and intermediates thereof

Country Status (20)

Country Link
US (1) US6043064A (de)
EP (1) EP0649907B1 (de)
JP (1) JP3683606B2 (de)
KR (1) KR100342627B1 (de)
CN (1) CN1085250C (de)
AT (1) ATE196166T1 (de)
AU (1) AU679113B2 (de)
CA (1) CA2134025A1 (de)
CY (1) CY2216B1 (de)
DE (1) DE69425801T2 (de)
DK (1) DK0649907T3 (de)
ES (1) ES2150459T3 (de)
FI (1) FI113279B (de)
GR (1) GR3034835T3 (de)
HK (1) HK1014740A1 (de)
HU (1) HU217104B (de)
IL (1) IL111084A (de)
PT (1) PT649907E (de)
SG (1) SG47504A1 (de)
TW (1) TW438888B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2299634C (en) 1997-08-07 2007-10-16 Kyowa Hakko Kogyo Co., Ltd. Process for the preparation of hmg-coa reductase inhibitors
EP1015600A1 (de) * 1997-08-22 2000-07-05 Dsm N.V. Fermentative herstellung von statin
SI9800144A (sl) * 1998-05-21 1999-12-31 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Nov biotehnološki postopek pridobivanja 3-hidroksi-ML-236B derivatov poznanih kot M-4 in M-4'
CZ20012622A3 (cs) 1999-01-20 2002-01-16 Kyowa Hakko Kogyo Co. Ltd. Proces přípravy inhibitorů HMG-CoA reduktázy
US7049111B1 (en) * 1999-01-29 2006-05-23 Kyowa Hakko Kogyo Co., Ltd. Process for producing HMG-CoA reductase inhibitor
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
JP2003093045A (ja) * 2001-09-26 2003-04-02 Godo Shusei Co Ltd 有用変換微生物
ATE316146T1 (de) * 2001-09-27 2006-02-15 Biocon Ltd Verfahren zur herstellung von pravastatin- natriumsalz mittels streptomyces flavidovirens dsm 14455
EP1452602A1 (de) * 2003-02-25 2004-09-01 Antibiotic Co., Fermentatives Verfahren zur Herstellung von Pravastatin
TWI252253B (en) * 2004-01-09 2006-04-01 Chinese Petroleum Corp A novel Pseudonocardia sp RMRC PAH4 and a process for bioconverting compactin into pravastatin using the same
JP5631534B2 (ja) 2005-11-29 2014-11-26 協和発酵バイオ株式会社 新規蛋白質および該蛋白質をコードするｄｎａ
WO2007137816A1 (en) * 2006-05-30 2007-12-06 Dsm Ip Assets B.V. Process for the preparation of epoxide intermediates for pharmaceutical compounds such as statins
EP1953233A1 (de) * 2007-02-02 2008-08-06 LEK Pharmaceuticals d.d. Fermentationsverfahren zur Herstellung von Pravastatin
EP3635110A2 (de) 2017-06-06 2020-04-15 Zymergen, Inc. Genomische hochdurchsatz-plattform (htp) zur verbesserung von saccharopolyspora spinosa

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (de) * 1974-06-07 1981-03-18
US4206206A (en) * 1977-03-24 1980-06-03 Kowa Company, Ltd. Antibiotics of the KA-6606 series and pharmaceutical compositions thereof
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
US4450171A (en) * 1980-08-05 1984-05-22 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3262386D1 (en) * 1981-06-06 1985-03-28 Pfizer Ltd Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
JPS60176595A (ja) * 1984-02-21 1985-09-10 Akira Endo 生理活性物質ｍｌ−２３６ａ及びモナコリンｊの製造法
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
EP0337548A3 (de) * 1988-04-15 1991-08-14 Merck & Co. Inc. Inhibitoren von HMG-COA-Reduktase, hergestellt durch Nocardia SP.(MA6455)(ATCC 53695)
EP0381478A1 (de) * 1989-02-01 1990-08-08 Merck & Co. Inc. Verfahren zur Herstellung von 6-alpha-Hydroxymethyl-Lovastatin-Derivaten
EP0408806A1 (de) * 1989-07-19 1991-01-23 Merck & Co. Inc. Antihypercholesterolemische Mittel
TW227552B (de) * 1990-07-06 1994-08-01 Squibb & Sons Inc
CA2053000C (en) * 1990-10-15 1995-08-29 Michael J. Conder Biosynthetic production of 6(r)-[2-(8(s)-hydroxy-2(s), 6(r)-dimethyl-1,2,6,7,8,8a(r)-hexahydronaphthyl)-ethyl]-4 (r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one triol acid by enzymatic hydrolysis of lovastatin acid using an enzyme derived from__lonostachys compactiuscula
IL108432A (en) * 1993-01-29 1997-09-30 Sankyo Co DERIVATIVES OF 3, 5-DIHYDROXY-7- £1, 2, 6, 7, 8, 8a-HEXAHYDRO-2- METHYL-8- (SUBSTITUTED ALKANOYLOXY)-1-NAPHTHYL| HEPTANOIC ACID AND THEIR LACTONES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
HUT69959A (en) 1995-09-28
FI113279B (fi) 2004-03-31
HK1014740A1 (en) 1999-09-30
FI944926A (fi) 1995-04-23
IL111084A0 (en) 1994-11-28
TW438888B (en) 2001-06-07
FI944926A0 (fi) 1994-10-20
JPH07184670A (ja) 1995-07-25
HU9403061D0 (en) 1994-12-28
ATE196166T1 (de) 2000-09-15
KR100342627B1 (ko) 2002-11-18
JP3683606B2 (ja) 2005-08-17
HU217104B (hu) 1999-11-29
DE69425801T2 (de) 2001-05-03
EP0649907B1 (de) 2000-09-06
DE69425801D1 (de) 2000-10-12
IL111084A (en) 1998-01-04
AU7597294A (en) 1995-05-11
US6043064A (en) 2000-03-28
CA2134025A1 (en) 1995-04-23
PT649907E (pt) 2000-12-29
ES2150459T3 (es) 2000-12-01
EP0649907A1 (de) 1995-04-26
DK0649907T3 (da) 2000-10-09
CN1106067A (zh) 1995-08-02
SG47504A1 (en) 1998-04-17
CN1085250C (zh) 2002-05-22
GR3034835T3 (en) 2001-02-28
KR950011616A (ko) 1995-05-15
AU679113B2 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
CY2216B1 (en) Enzymatic hydroxylation process for the preparation of hmg-coa reductase inhibitors and intermediates thereof
WO1997040141A3 (en) Isolation of enzymes
CA2311756A1 (en) Reduction of hair growth
AU7508794A (en) Novel lipase, microorganism producing the lipase, process for producing the lipase, and use of the lipase
MX9702724A (es) Lipasa, microorganismo que la produce, procedimiento para la preparacion de dicha lipasa y su uso.
AU3075697A (en) Enzymatic process for the manufacture of ascorbic acid, 2-keto-l-gulonic acid and esters of 2-keto-l-gulonic acid
AU3197993A (en) Enzymatic resolution of endo-bicyclo{2.2.1}heptan-2-ol and conversion products thereof
AU7610200A (en) Improved fermentation process
WO2000039276A3 (en) Microbial transformation method for the preparation of an epothilone
EP0896057A3 (de) D-Aminoacylase
EP0826773A3 (de) Verfahren zur Herstellung von trans-4-Hydroxy-L-Prolin
AU8334798A (en) A composition comprising an enzyme having galactose oxidase activity and use thereof
AU1273000A (en) Process for preparing optically active-3-hydroxy-pyrrolidine derivatives by enzymatic hydroxylation
HK1109782A1 (en) Microorganisms
AU8978398A (en) Process for preparing amides
AU3362689A (en) Gene and gene product for preparing beta-lactam compounds
AU2818392A (en) Method for enhancing enzyme activities and the synthetic performance of organisms
EP0283123A3 (de) Zwischenprodukte und Verfahren zur Herstellung von HMG-COA-Reduktase-Inhibitoren
ATE161584T1 (de) Esterase und ihre verwendung in bioumwandlung
EP0909757A3 (de) Verfahren zur Herstellung optisch aktiver Pentatetraole
CA2131776A1 (en) Process for producing cis-3-hydroxy-l-proline
AU2001265994A1 (en) Method for microbial production of difructose anhydride iii, micro-organism usedtherefor and enzyme with inulase ii activity and dna sequences coding therefor
HUT70310A (en) Method for selecting recobinant microorganisms of which the surface comprises at least one molecule having enzymatic activity
AU2001291811A1 (en) Method for an enzymatic reaction of compounds having at least one nitrile function and/or at least one amide function
IT1255470B (it) Composti attivi come inibitori dell'enzima hmg-coa reduttasi